From The Lab Bench
Approximately 570,000 cases of cervical cancer and 311,000 deaths from the disease occurred worldwide in 2018. Cervical cancer is the fourth most common cancer in women, ranking after breast cancer, colorectal cancer and lung cancer. Cervical Cancer Screening is used to find changes in the cells of the cervix that could lead to cancer.
At Jahmale Medical Solutions, screening for cervical cancer includes cervical cytology (also known as Pap Smear or Pap Test) and testing for the human papillomavirus (HPV), which causes the majority of cervical cancer cases. Both tests use cells taken from the cervix. The sample collection process is simple and fast. You lie on an exam table and a speculum is used to open the vagina. Cells are removed from the cervix with a brush. The cells are then put into a special liquid and sent to the laboratory for testing. For the Pap Smear, the sample is examined to see if abnormal cells are present. For an HPV test, the sample is tested for the presence of the most common high-risk HPV types. There are more than 100 types of HPV, of which at least 14 are cancer-causing (also known as high risk type).
Ask your healthcare provider about cervical cancer testing today.
Jahmale is here to help!
Stanley Zilevu, BsC.
Jahmale Medical Solution